Epione has created a highly-efficacious, non-opioid pain medication that is poised to enter the $40 billion pain market in 18 months or less.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free